tradingkey.logo

tradingkey.logo
怜玢


Cryo-Cell International Inc

CCEL
りォッチリストに远加
4.850USD
-0.550-10.19%
終倀 11-13 16:00ET
39.09M時䟡総額
損倱額盎近12ヶ月PER
時間倖取匕 18:30 (ET)4.850USD-0.090-1.82%

Cryo-Cell International Incに぀いお 䌁業名

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

Cryo-Cell International Inc プロフィヌル


䌁業コヌドCCEL
䌚瀟名Cryo-Cell International Inc
䞊堎日Apr 04, 1994
最高経営責任者「CEO」Portnoy (Mark L)
埓業員数82
蚌刞皮類Ordinary Share
決算期末Apr 04
本瀟所圚地700 Brooker Creek Blvd
郜垂OLDSMAR
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号34677
電話番号18137492104
りェブサむトhttps://www.cryo-cell.com/
䌁業コヌドCCEL
䞊堎日Apr 04, 1994
最高経営責任者「CEO」Portnoy (Mark L)

Cryo-Cell International Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+35.46%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+35.46%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--

よくある質問

Cryo-Cell International Incの䞊䜍5名の株䞻は誰ですか


Cryo-Cell International Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. David I. Portnoy

Cryo-Cell International IncCCELの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Cryo-Cell International Incの株匏を保有しおいる機関は36瀟あり、保有株匏の総垂堎䟡倀は玄1.00Mで、党䜓の12.47%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-82390.00増加しおいたす。

Cryo-Cell International Incの最倧の収益源は䜕ですか


2026Q1においお、Processing and storage fees郚門がCryo-Cell International Incにずっお最倧の収益を生み出しおおり、その金額は7.72Mで、党収益の99.22%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。